Source: GlobalNewswire

Press Release: Bioject : Inovio Pharmaceuticals Completes Acquisition of Needle-Free Injection Technology

Read full article »
Bioject's Competitors | Bioject's News | Bioject's Financials
Stay up-to-date with the latest news on Bioject
Annual Revenue
$100K-5.0M
Employees
25-100
Tony K. Chow's photo - President & CEO of Bioject

President & CEO

Tony K. Chow

CEO Approval Rating

69/100

Read more
Stay up-to-date with the latest news on Bioject